These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1321944)

  • 1. Oestrogen and cyclical progestogen in postmenopausal hormone replacement therapy.
    MacLennan AH; MacLennan A; O'Neill S; Kirkgard Y; Wenzel S; Chambers HM
    Med J Aust; 1992 Aug; 157(3):167-70. PubMed ID: 1321944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous low-dose oestrogen and progestogen hormone replacement therapy: a randomised trial.
    MacLennan AH; MacLennan A; Wenzel S; Chambers HM; Eckert K
    Med J Aust; 1993 Jul; 159(2):102-6. PubMed ID: 8336583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous estrogen/progestin therapy in menopause.
    Prough SG; Aksel S; Wiebe RH; Shepherd J
    Am J Obstet Gynecol; 1987 Dec; 157(6):1449-53. PubMed ID: 2827483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy.
    Luciano AA; Turksoy RN; Carleo J; Hendrix JW
    Obstet Gynecol; 1988 Jan; 71(1):39-43. PubMed ID: 2827082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
    Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of conjugated estrogen plus medroxyprogesterone acetate versus tibolone in early postmenopausal Chinese women.
    Yang TS; Tsan SH; Chen CR; Chang SP; Yuan CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 May; 62(5):308-15. PubMed ID: 10389286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women.
    Barnes RB; Roy S; Lobo RA
    Obstet Gynecol; 1985 Aug; 66(2):216-9. PubMed ID: 2991832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of continuous versus sequential estrogen and progestin therapy in postmenopausal women.
    Clisham PR; de Ziegler D; Lozano K; Judd HL
    Obstet Gynecol; 1991 Feb; 77(2):241-6. PubMed ID: 1846438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Provera the ideal progestogen for addition to postmenopausal estrogen therapy?
    Lane G; Siddle NC; Ryder TA; Pryse-Davies J; King RJ; Whitehead MI
    Fertil Steril; 1986 Mar; 45(3):345-52. PubMed ID: 3005052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
    Gallagher JC; Kable WT; Goldgar D
    Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women.
    Gibbons WE; Moyer DL; Lobo RA; Roy S; Mishell DR
    Am J Obstet Gynecol; 1986 Feb; 154(2):456-61. PubMed ID: 3004222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: a randomized trial.
    AinMelk Y
    Fertil Steril; 1996 Dec; 66(6):962-8. PubMed ID: 8941062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential use of conjugated estrogens and medroxyprogesterone in the climacteric syndrome: clinical and histological findings.
    Figueroa-Casas PR; Schlaen I
    Maturitas; 1988 Mar; 9(4):309-13. PubMed ID: 2837619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate.
    Lemay A; Dodin S; Cédrin I; T-Lemay L
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):341-51. PubMed ID: 7750187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined continuous hormone replacement therapy: a critical review.
    Udoff L; Langenberg P; Adashi EY
    Obstet Gynecol; 1995 Aug; 86(2):306-16. PubMed ID: 7617369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of continuous administration of conjugated estrogen plus medroxyprogesterone acetate (Premelle) in postmenopausal women in Taiwan.
    Yang TS; Wang HL; Chen YJ; Chang SP; Yuan CC
    J Chin Med Assoc; 2004 Jul; 67(7):336-43. PubMed ID: 15510930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.
    Hargrove JT; Maxson WS; Wentz AC; Burnett LS
    Obstet Gynecol; 1989 Apr; 73(4):606-12. PubMed ID: 2538787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin.
    Bewtra C; Kable WT; Gallagher JC
    J Reprod Med; 1988 Feb; 33(2):205-8. PubMed ID: 2832598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of near-continuous oral micronized progesterone therapy in estrogenized postmenopausal women.
    Bolaji II; Mortimer G; Grimes H; Tallon DF; O'Dwyer E; Fottrell PF
    Gynecol Endocrinol; 1996 Feb; 10(1):41-7. PubMed ID: 8737191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
    Langer RD; Landgren BM; Rymer J; Helmond FA;
    Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.